| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 COL5A3 COL6A5 | 3.60e-15 | 46 | 84 | 10 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 EMILIN2 COL5A3 COL6A5 SSPOP | 2.13e-11 | 188 | 84 | 12 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 KRT78 COL13A1 COL16A1 EMILIN2 COL5A3 COL6A5 SSPOP | 8.45e-05 | 891 | 84 | 13 | GO:0005198 |
| GeneOntologyMolecularFunction | collagen binding | 3.79e-04 | 81 | 84 | 4 | GO:0005518 | |
| GeneOntologyMolecularFunction | PH domain binding | 6.18e-04 | 9 | 84 | 2 | GO:0042731 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.40e-05 | 12 | 84 | 3 | GO:0038063 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 3.09e-05 | 392 | 84 | 9 | GO:0070588 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 4.13e-05 | 509 | 84 | 10 | GO:0006816 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 5.09e-05 | 18 | 84 | 3 | GO:0038065 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.50e-04 | 377 | 84 | 8 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.53e-04 | 378 | 84 | 8 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.56e-04 | 379 | 84 | 8 | GO:0045229 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 1.78e-04 | 493 | 84 | 9 | GO:0010959 | |
| GeneOntologyCellularComponent | collagen trimer | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 C1QTNF9B EMILIN2 SFTPA1 COL5A3 COL6A5 | 2.55e-17 | 88 | 84 | 13 | GO:0005581 |
| GeneOntologyCellularComponent | collagen type IV trimer | 3.62e-09 | 6 | 84 | 4 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 1.68e-08 | 8 | 84 | 4 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 1.68e-08 | 8 | 84 | 4 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 1.68e-08 | 8 | 84 | 4 | GO:0098645 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.80e-08 | 21 | 84 | 5 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 ACHE EMILIN2 SFTPA1 COL5A3 COL6A5 SSPOP | 2.39e-08 | 530 | 84 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 LRRC24 ACHE EMILIN2 SFTPA1 COL5A3 COL6A5 SSPOP | 4.79e-08 | 656 | 84 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 LRRC24 ACHE EMILIN2 SFTPA1 COL5A3 COL6A5 SSPOP | 4.99e-08 | 658 | 84 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 ACHE COL5A3 | 8.70e-07 | 332 | 84 | 10 | GO:0005788 |
| GeneOntologyCellularComponent | basement membrane | 1.33e-04 | 122 | 84 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | postsynaptic density | 2.25e-03 | 451 | 84 | 7 | GO:0014069 | |
| HumanPheno | Glomerular basement membrane lamellation | 1.49e-07 | 3 | 28 | 3 | HP:0030034 | |
| HumanPheno | Anterior lenticonus | 1.49e-07 | 3 | 28 | 3 | HP:0011501 | |
| HumanPheno | Lenticonus | 1.50e-07 | 10 | 28 | 4 | HP:0001142 | |
| HumanPheno | Abnormality of lens shape | 2.12e-06 | 18 | 28 | 4 | HP:0011526 | |
| HumanPheno | Alzheimer disease | 1.22e-05 | 9 | 28 | 3 | HP:0002511 | |
| HumanPheno | Tracheobronchial leiomyomatosis | 2.91e-05 | 2 | 28 | 2 | HP:0006524 | |
| HumanPheno | Dyspepsia | 2.91e-05 | 2 | 28 | 2 | HP:0410281 | |
| HumanPheno | Diffuse leiomyomatosis | 2.91e-05 | 2 | 28 | 2 | HP:0006756 | |
| HumanPheno | Thickened glomerular basement membrane | 3.17e-05 | 12 | 28 | 3 | HP:0004722 | |
| HumanPheno | Abnormal glomerular basement membrane morphology | 4.10e-05 | 13 | 28 | 3 | HP:0033282 | |
| HumanPheno | Abnormal urine cytology | 5.11e-05 | 188 | 28 | 7 | HP:0012614 | |
| HumanPheno | Hematuria | 5.11e-05 | 188 | 28 | 7 | HP:0000790 | |
| HumanPheno | Glomerular subepithelial deposits | 5.20e-05 | 14 | 28 | 3 | HP:0033603 | |
| HumanPheno | Hand oligodactyly | 8.71e-05 | 3 | 28 | 2 | HP:0001180 | |
| HumanPheno | Hand monodactyly | 8.71e-05 | 3 | 28 | 2 | HP:0004058 | |
| HumanPheno | Vulvar neoplasm | 8.71e-05 | 3 | 28 | 2 | HP:0030416 | |
| HumanPheno | Precordial pain | 8.71e-05 | 3 | 28 | 2 | HP:0032141 | |
| HumanPheno | Thin glomerular basement membrane | 8.71e-05 | 3 | 28 | 2 | HP:0012577 | |
| HumanPheno | Glomerular deposits | 1.59e-04 | 20 | 28 | 3 | HP:0030949 | |
| HumanPheno | Bifid femur | 1.74e-04 | 4 | 28 | 2 | HP:0010443 | |
| HumanPheno | Albuminuria | 2.14e-04 | 22 | 28 | 3 | HP:0012592 | |
| HumanPheno | Abnormal nephron morphology | 4.61e-04 | 451 | 28 | 9 | HP:0012575 | |
| HumanPheno | Proteinuria | 5.26e-04 | 273 | 28 | 7 | HP:0000093 | |
| HumanPheno | Abnormal urine protein level | 5.26e-04 | 273 | 28 | 7 | HP:0020129 | |
| HumanPheno | Microscopic hematuria | 6.03e-04 | 31 | 28 | 3 | HP:0002907 | |
| MousePheno | renal interstitial fibrosis | 5.73e-06 | 54 | 67 | 5 | MP:0003215 | |
| MousePheno | abnormal kidney interstitium morphology | 1.67e-05 | 67 | 67 | 5 | MP:0011425 | |
| MousePheno | renal fibrosis | 3.50e-05 | 78 | 67 | 5 | MP:0003985 | |
| MousePheno | kidney failure | 6.76e-05 | 46 | 67 | 4 | MP:0003606 | |
| MousePheno | expanded mesangial matrix | 6.76e-05 | 46 | 67 | 4 | MP:0011353 | |
| MousePheno | hematuria | 9.65e-05 | 19 | 67 | 3 | MP:0005161 | |
| MousePheno | abnormal mesangial matrix morphology | 1.02e-04 | 51 | 67 | 4 | MP:0011338 | |
| Domain | Collagen | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 C1QTNF9B SFTPA1 COL5A3 COL6A5 | 2.63e-15 | 85 | 83 | 12 | IPR008160 |
| Domain | Collagen | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 C1QTNF9B SFTPA1 COL5A3 COL6A5 | 2.63e-15 | 85 | 83 | 12 | PF01391 |
| Domain | C4 | 5.40e-09 | 6 | 83 | 4 | SM00111 | |
| Domain | - | 5.40e-09 | 6 | 83 | 4 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 5.40e-09 | 6 | 83 | 4 | IPR001442 | |
| Domain | C4 | 5.40e-09 | 6 | 83 | 4 | PF01413 | |
| Domain | NC1_IV | 5.40e-09 | 6 | 83 | 4 | PS51403 | |
| Domain | CTDL_fold | 8.10e-06 | 107 | 83 | 6 | IPR016187 | |
| Domain | TSPN | 1.41e-04 | 23 | 83 | 3 | SM00210 | |
| Domain | PKD/Chitinase_dom | 6.88e-04 | 9 | 83 | 2 | IPR022409 | |
| Domain | PKD | 6.88e-04 | 9 | 83 | 2 | SM00089 | |
| Domain | Fib_collagen_C | 1.05e-03 | 11 | 83 | 2 | IPR000885 | |
| Domain | PKD | 1.05e-03 | 11 | 83 | 2 | PS50093 | |
| Domain | PKD_dom | 1.05e-03 | 11 | 83 | 2 | IPR000601 | |
| Domain | COLFI | 1.05e-03 | 11 | 83 | 2 | PF01410 | |
| Domain | NC1_FIB | 1.05e-03 | 11 | 83 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 1.05e-03 | 11 | 83 | 2 | PD002078 | |
| Domain | COLFI | 1.05e-03 | 11 | 83 | 2 | SM00038 | |
| Domain | - | 1.05e-03 | 11 | 83 | 2 | 2.60.40.670 | |
| Domain | LDLRA_1 | 1.27e-03 | 48 | 83 | 3 | PS01209 | |
| Domain | LDLRA_2 | 1.35e-03 | 49 | 83 | 3 | PS50068 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 COL5A3 COL6A5 | 3.31e-15 | 44 | 63 | 10 | M27812 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A3 COL4A4 COL4A5 COL4A6 COL6A2 COL13A1 COL16A1 COL5A3 COL6A5 | 1.23e-13 | 41 | 63 | 9 | MM15538 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 COL5A3 COL6A5 | 3.06e-13 | 67 | 63 | 10 | M26999 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A3 COL4A4 COL4A5 COL4A6 COL6A2 COL13A1 COL16A1 COL5A3 COL6A5 | 5.67e-12 | 61 | 63 | 9 | MM14637 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 COL5A3 COL6A5 | 6.53e-12 | 90 | 63 | 10 | M631 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A3 COL4A4 COL4A5 COL4A6 COL6A2 COL13A1 COL16A1 COL5A3 COL6A5 | 8.92e-12 | 64 | 63 | 9 | M26953 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A3 COL4A4 COL4A5 COL4A6 COL6A2 COL13A1 COL16A1 COL5A3 COL6A5 | 4.43e-11 | 76 | 63 | 9 | MM14573 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL4A3 COL4A4 COL4A5 COL4A6 COL6A2 COL13A1 COL16A1 COL5A3 COL6A5 | 4.43e-11 | 76 | 63 | 9 | MM14867 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 7.60e-11 | 53 | 63 | 8 | MM14566 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL4A3 COL4A4 COL4A5 COL4A6 COL6A2 COL13A1 COL16A1 COL5A3 COL6A5 | 1.24e-10 | 85 | 63 | 9 | M16441 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.30e-10 | 20 | 63 | 6 | MM15061 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.46e-10 | 61 | 63 | 8 | M27103 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 6.03e-10 | 42 | 63 | 7 | M7169 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.18e-09 | 46 | 63 | 7 | M198 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.17e-09 | 50 | 63 | 7 | MM14796 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A3 COL4A4 COL4A5 COL4A6 COL6A2 COL13A1 COL16A1 COL5A3 COL6A5 | 1.09e-08 | 140 | 63 | 9 | M587 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.15e-08 | 63 | 63 | 7 | M11187 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.54e-08 | 38 | 63 | 6 | MM14969 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 3.60e-08 | 74 | 63 | 7 | M160 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.82e-08 | 114 | 63 | 8 | MM14571 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.34e-08 | 76 | 63 | 7 | M27219 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 7.45e-08 | 10 | 63 | 4 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 7.45e-08 | 10 | 63 | 4 | MM1560 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 EMILIN2 COL5A3 COL6A5 | 7.77e-08 | 300 | 63 | 11 | M610 |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.17e-07 | 11 | 63 | 4 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.75e-07 | 12 | 63 | 4 | MM1526 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.90e-07 | 57 | 63 | 6 | MM14713 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A3 COL4A4 COL4A5 COL4A6 COL6A2 COL13A1 COL16A1 EMILIN2 COL5A3 COL6A5 | 1.93e-07 | 258 | 63 | 10 | MM14572 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.11e-07 | 58 | 63 | 6 | M2049 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.51e-07 | 13 | 63 | 4 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.51e-07 | 13 | 63 | 4 | M12950 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.78e-07 | 32 | 63 | 5 | MM14924 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.51e-07 | 14 | 63 | 4 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.51e-07 | 14 | 63 | 4 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.76e-07 | 15 | 63 | 4 | MM14922 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 4.76e-07 | 15 | 63 | 4 | M27161 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.06e-06 | 18 | 63 | 4 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.06e-06 | 18 | 63 | 4 | MM14882 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.66e-06 | 20 | 63 | 4 | M15394 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 3.01e-06 | 23 | 63 | 4 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 3.01e-06 | 23 | 63 | 4 | MM1427 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 6.31e-06 | 59 | 63 | 5 | M27218 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 9.10e-06 | 30 | 63 | 4 | M27216 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.10e-05 | 66 | 63 | 5 | M18 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.57e-05 | 84 | 63 | 5 | M7098 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 3.92e-05 | 43 | 63 | 4 | M53 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 4.70e-05 | 45 | 63 | 4 | M39864 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 8.02e-05 | 161 | 63 | 6 | M39770 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.57e-04 | 261 | 63 | 7 | MM15676 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 3.66e-04 | 502 | 63 | 9 | MM14537 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 7.16e-04 | 439 | 63 | 8 | M42563 | |
| Pathway | WP_PI3KAKT_SIGNALING | 7.61e-04 | 339 | 63 | 7 | M39736 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 8.85e-04 | 96 | 63 | 4 | M39834 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.20e-03 | 47 | 63 | 3 | MM14925 | |
| Pathway | WP_CANCER_PATHWAYS | 1.80e-03 | 507 | 63 | 8 | M48302 | |
| Pathway | WP_GPR40_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M39526 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.43e-03 | 532 | 63 | 8 | M27870 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.54e-03 | 418 | 63 | 7 | MM15587 | |
| Pathway | WP_ACE_INHIBITOR_PATHWAY | 2.56e-03 | 17 | 63 | 2 | M39680 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.92e-03 | 575 | 63 | 8 | M29853 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.07e-03 | 72 | 63 | 3 | M39403 | |
| Pubmed | COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 EMILIN2 SFTPA1 COL5A3 COL6A5 | 3.52e-13 | 167 | 85 | 11 | 22159717 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL4A3 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 EMILIN2 COL5A3 COL6A5 | 1.35e-12 | 135 | 85 | 10 | 28675934 |
| Pubmed | 9.68e-12 | 9 | 85 | 5 | 12101409 | ||
| Pubmed | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL16A1 COL5A3 COL6A5 SSPOP | 1.81e-11 | 175 | 85 | 10 | 28071719 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 1.79e-10 | 62 | 85 | 7 | 28344315 | |
| Pubmed | 4.96e-10 | 6 | 85 | 4 | 2426947 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 4.96e-10 | 6 | 85 | 4 | 10534397 | |
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 4.96e-10 | 6 | 85 | 4 | 19275937 | |
| Pubmed | 4.96e-10 | 6 | 85 | 4 | 6988303 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 4.96e-10 | 6 | 85 | 4 | 9506531 | |
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 4.96e-10 | 6 | 85 | 4 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 4.96e-10 | 6 | 85 | 4 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 4.96e-10 | 6 | 85 | 4 | 6389236 | |
| Pubmed | 4.96e-10 | 6 | 85 | 4 | 12225806 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 4.96e-10 | 6 | 85 | 4 | 9673377 | |
| Pubmed | 4.96e-10 | 6 | 85 | 4 | 11732842 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 1.16e-09 | 7 | 85 | 4 | 8006028 | |
| Pubmed | 1.16e-09 | 7 | 85 | 4 | 10416788 | ||
| Pubmed | 1.16e-09 | 7 | 85 | 4 | 11711546 | ||
| Pubmed | 1.16e-09 | 7 | 85 | 4 | 1724753 | ||
| Pubmed | 2.31e-09 | 8 | 85 | 4 | 3997552 | ||
| Pubmed | Type IV collagen α6 chain is a regulator of keratin 10 in keratinization of oral mucosal epithelium. | 2.31e-09 | 8 | 85 | 4 | 29422532 | |
| Pubmed | 2.31e-09 | 8 | 85 | 4 | 10382266 | ||
| Pubmed | 4.15e-09 | 9 | 85 | 4 | 9878537 | ||
| Pubmed | 4.22e-09 | 153 | 85 | 8 | 25037231 | ||
| Pubmed | 6.90e-09 | 10 | 85 | 4 | 9136074 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 1.08e-08 | 11 | 85 | 4 | 7500359 | |
| Pubmed | 1.08e-08 | 11 | 85 | 4 | 14998921 | ||
| Pubmed | Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. | 1.41e-08 | 3 | 85 | 3 | 27576055 | |
| Pubmed | A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers. | 1.41e-08 | 3 | 85 | 3 | 24522496 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 7962065 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 28704582 | ||
| Pubmed | Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS. | 1.41e-08 | 3 | 85 | 3 | 30647093 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 36130833 | ||
| Pubmed | Genetic diagnosis of Alport syndrome in 16 Chinese families. | 1.41e-08 | 3 | 85 | 3 | 38433557 | |
| Pubmed | COL4A6 is dispensable for autosomal recessive Alport syndrome. | 1.41e-08 | 3 | 85 | 3 | 27377778 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 14633121 | ||
| Pubmed | Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. | 1.41e-08 | 3 | 85 | 3 | 15954103 | |
| Pubmed | Alport syndrome: impact of digenic inheritance in patients management. | 1.41e-08 | 3 | 85 | 3 | 27859054 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 17396119 | ||
| Pubmed | Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome. | 1.41e-08 | 3 | 85 | 3 | 28542346 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 18930919 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 38978054 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 20301386 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 14507670 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 25575550 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 24033287 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 1.62e-08 | 12 | 85 | 4 | 15837576 | |
| Pubmed | 1.62e-08 | 12 | 85 | 4 | 16024816 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 1.62e-08 | 12 | 85 | 4 | 12180907 | |
| Pubmed | 3.26e-08 | 14 | 85 | 4 | 12878203 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 20664914 | ||
| Pubmed | 5.91e-08 | 16 | 85 | 4 | 15878328 | ||
| Pubmed | 1.25e-07 | 19 | 85 | 4 | 15689378 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 7495302 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCNX2 PRR12 COL4A5 LRRC24 FNTB ZNF592 PKD1 MLLT6 CAMSAP1 PLEKHG5 ULK2 FBXO46 ABCA7 ARHGAP33 | 4.58e-07 | 1105 | 85 | 14 | 35748872 |
| Pubmed | 4.77e-07 | 26 | 85 | 4 | 24742657 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 4.90e-07 | 7 | 85 | 3 | 10716744 | |
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 7521231 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 17418794 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 10639489 | ||
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 1377218 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 7.82e-07 | 8 | 85 | 3 | 10970885 | |
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 1383086 | ||
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 11683410 | ||
| Pubmed | 8.77e-07 | 210 | 85 | 7 | 16537572 | ||
| Pubmed | 9.94e-07 | 31 | 85 | 4 | 22925884 | ||
| Pubmed | 1.17e-06 | 9 | 85 | 3 | 8562707 | ||
| Pubmed | Loss of the collagen IV modifier prolyl 3-hydroxylase 2 causes thin basement membrane nephropathy. | 1.17e-06 | 9 | 85 | 3 | 35499085 | |
| Pubmed | 1.67e-06 | 10 | 85 | 3 | 9415455 | ||
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 2.29e-06 | 11 | 85 | 3 | 9731539 | |
| Pubmed | 2.84e-06 | 40 | 85 | 4 | 27068110 | ||
| Pubmed | 3.05e-06 | 12 | 85 | 3 | 8918877 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 3.96e-06 | 13 | 85 | 3 | 9833687 | |
| Pubmed | 5.03e-06 | 14 | 85 | 3 | 19858219 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 9537506 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 9195222 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 7987396 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 29742505 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 38214412 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19920353 | ||
| Pubmed | Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. | 5.90e-06 | 2 | 85 | 2 | 8356449 | |
| Pubmed | COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. | 5.90e-06 | 2 | 85 | 2 | 24052634 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19357112 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21143337 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 28632965 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 25229338 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 10965041 | ||
| Pubmed | Persistent familial hematuria in children and the locus for thin basement membrane nephropathy. | 5.90e-06 | 2 | 85 | 2 | 16235097 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15211113 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 20951201 | ||
| Pubmed | Presumed COL4A3/COL4A4 Missense/Synonymous Variants Induce Aberrant Splicing. | 5.90e-06 | 2 | 85 | 2 | 35386907 | |
| Pubmed | COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. | 5.90e-06 | 2 | 85 | 2 | 12028435 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 18661361 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15598179 | ||
| Pubmed | Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family. | 5.90e-06 | 2 | 85 | 2 | 28674241 | |
| Pubmed | Heterozygous COL4A3/COL4A4 mutations: the hidden part of the iceberg? | 5.90e-06 | 2 | 85 | 2 | 35090027 | |
| Pubmed | Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases. | 5.90e-06 | 2 | 85 | 2 | 17216251 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 35369551 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 35177655 | ||
| Interaction | HABP2 interactions | 8.62e-07 | 18 | 85 | 4 | int:HABP2 | |
| Interaction | OSM interactions | 1.36e-06 | 20 | 85 | 4 | int:OSM | |
| Interaction | SERPINE2 interactions | 3.82e-06 | 56 | 85 | 5 | int:SERPINE2 | |
| Interaction | COLGALT2 interactions | 9.32e-06 | 67 | 85 | 5 | int:COLGALT2 | |
| Interaction | MMP9 interactions | 9.32e-06 | 67 | 85 | 5 | int:MMP9 | |
| Interaction | DCN interactions | 3.21e-05 | 43 | 85 | 4 | int:DCN | |
| Interaction | CD93 interactions | 3.85e-05 | 45 | 85 | 4 | int:CD93 | |
| Interaction | LAIR2 interactions | 5.40e-05 | 49 | 85 | 4 | int:LAIR2 | |
| Cytoband | Xq22 | 7.82e-04 | 22 | 86 | 2 | Xq22 | |
| Cytoband | 19p13.3 | 1.06e-03 | 237 | 86 | 4 | 19p13.3 | |
| Cytoband | 7q36 | 1.18e-03 | 27 | 86 | 2 | 7q36 | |
| Cytoband | 8q24.3 | 1.28e-03 | 113 | 86 | 3 | 8q24.3 | |
| Cytoband | 11q13 | 1.45e-03 | 118 | 86 | 3 | 11q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q36 | 3.38e-03 | 159 | 86 | 3 | chr7q36 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 3.90e-03 | 797 | 86 | 6 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq22 | 4.21e-03 | 172 | 86 | 3 | chrXq22 | |
| GeneFamily | Collagens | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 COL5A3 COL6A5 | 1.07e-16 | 46 | 55 | 10 | 490 |
| Coexpression | NABA_COLLAGENS | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 COL5A3 COL6A5 | 1.31e-16 | 43 | 85 | 10 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 COL5A3 COL6A5 | 1.69e-16 | 44 | 85 | 10 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 EMILIN2 COL5A3 COL6A5 SSPOP | 7.55e-11 | 270 | 85 | 12 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 EMILIN2 COL5A3 COL6A5 SSPOP | 9.33e-11 | 275 | 85 | 12 | M5884 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.42e-09 | 40 | 85 | 6 | M5887 | |
| Coexpression | NABA_MATRISOME | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 AMH COL13A1 COL16A1 C1QTNF9B EMILIN2 SFTPA1 COL5A3 COL6A5 SSPOP PLXNB3 | 1.32e-07 | 1008 | 85 | 16 | MM17056 |
| Coexpression | NABA_MATRISOME | COL4A3 COL4A4 COL4A5 COL4A6 COL24A1 COL6A2 AMH COL13A1 COL16A1 C1QTNF9B EMILIN2 SFTPA1 COL5A3 COL6A5 SSPOP PLXNB3 | 1.68e-07 | 1026 | 85 | 16 | M5889 |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | PCNX2 COL13A1 UNCX ACHE BHLHA9 ADGRB1 FZD10 CACNA1G ECEL1 GRIN3B VSX1 | 1.76e-07 | 438 | 85 | 11 | M1954 |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | PCNX2 COL13A1 UNCX ACHE BHLHA9 ADGRB1 FZD10 CACNA1G ECEL1 GRIN3B VSX1 | 1.84e-07 | 440 | 85 | 11 | MM832 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 8.70e-07 | 23 | 85 | 4 | M48001 | |
| Coexpression | GU_PDEF_TARGETS_UP | 3.50e-06 | 71 | 85 | 5 | M3955 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN | 4.72e-05 | 199 | 85 | 6 | M6048 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 9.10e-05 | 27 | 85 | 3 | M47994 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | 1.27e-04 | 591 | 85 | 9 | M2019 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | 1.44e-04 | 601 | 85 | 9 | MM866 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.46e-09 | 196 | 86 | 8 | 614a07334707eafe238d5cb7b080a3ca796a1920 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.01e-08 | 180 | 86 | 7 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.80e-08 | 187 | 86 | 7 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.12e-07 | 157 | 86 | 6 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.79e-07 | 167 | 86 | 6 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.79e-07 | 167 | 86 | 6 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 9.42e-07 | 169 | 86 | 6 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-06 | 179 | 86 | 6 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-06 | 180 | 86 | 6 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-06 | 188 | 86 | 6 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.81e-06 | 189 | 86 | 6 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.16e-06 | 195 | 86 | 6 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.29e-06 | 197 | 86 | 6 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.29e-06 | 197 | 86 | 6 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 2.36e-06 | 198 | 86 | 6 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.36e-06 | 198 | 86 | 6 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.79e-06 | 121 | 86 | 5 | 5035e071033cb76a7fc0128716755b14821e8f05 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.79e-06 | 121 | 86 | 5 | c96115bd33455296378a257583b49442d00b39ca | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.47e-06 | 135 | 86 | 5 | c4d3c9eba2a85ac40fea5ecfcc2b442a472323d0 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.99e-06 | 141 | 86 | 5 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.99e-06 | 141 | 86 | 5 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-05 | 167 | 86 | 5 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 167 | 86 | 5 | cf6206c506715cd846799c62cf7c06e3fa99f7af | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.81e-05 | 167 | 86 | 5 | 589c0acfeb4d70931b6726fb3331d85a54e74d56 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-05 | 167 | 86 | 5 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 169 | 86 | 5 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-05 | 169 | 86 | 5 | cd16e8462ee09877be962fbd9a3badcb825820b0 | |
| ToppCell | AT1-AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.27e-05 | 175 | 86 | 5 | 9a95ab5c361ebaa8747983c5a0d69025682a19ad | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.53e-05 | 179 | 86 | 5 | cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.60e-05 | 180 | 86 | 5 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-05 | 181 | 86 | 5 | 634a4f4e5942473e60d08d0b0936407b04bc6b7c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-05 | 181 | 86 | 5 | c2938cf1f5d4875be07a56a1f36c94f8eab37d99 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 181 | 86 | 5 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 181 | 86 | 5 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.74e-05 | 182 | 86 | 5 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-05 | 182 | 86 | 5 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-05 | 182 | 86 | 5 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-05 | 184 | 86 | 5 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-05 | 184 | 86 | 5 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.89e-05 | 184 | 86 | 5 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-05 | 185 | 86 | 5 | 38486b69c48dc5e1c4e1488208fa8954a973eccb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-05 | 185 | 86 | 5 | 3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 186 | 86 | 5 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 186 | 86 | 5 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 187 | 86 | 5 | 908df5520142d65fe32a003d26be14965082a1ea | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 187 | 86 | 5 | c1dfab0b0d7f519b9f13f4e0365ab41c4b2ae1ec | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.12e-05 | 187 | 86 | 5 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.12e-05 | 187 | 86 | 5 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.12e-05 | 187 | 86 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 187 | 86 | 5 | b486cc5ac678051fea9d4c7db53b26a5a8427e60 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.12e-05 | 187 | 86 | 5 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.12e-05 | 187 | 86 | 5 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | AT1-AT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.20e-05 | 188 | 86 | 5 | be710bc957118cf426dd71c2d57e6f1b41c9a467 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-05 | 189 | 86 | 5 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 189 | 86 | 5 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.36e-05 | 190 | 86 | 5 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.36e-05 | 190 | 86 | 5 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 191 | 86 | 5 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.45e-05 | 191 | 86 | 5 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 192 | 86 | 5 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.54e-05 | 192 | 86 | 5 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 192 | 86 | 5 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 192 | 86 | 5 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 3.54e-05 | 192 | 86 | 5 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 3.81e-05 | 195 | 86 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.81e-05 | 195 | 86 | 5 | 5870b2956d50d6550a3174a220a6cc70c5538d70 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-05 | 195 | 86 | 5 | 51db90e7611f7d69980878c046505ff34212079b | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.00e-05 | 197 | 86 | 5 | 22b26bac3a99b20c73bfa6e6f81026d064eaa9e8 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.00e-05 | 197 | 86 | 5 | f7eaac1c321710a55e09ffb047a7db2baf7b7e28 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.00e-05 | 197 | 86 | 5 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.19e-05 | 199 | 86 | 5 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.19e-05 | 199 | 86 | 5 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.19e-05 | 199 | 86 | 5 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.19e-05 | 199 | 86 | 5 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.19e-05 | 199 | 86 | 5 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | Tracheal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.19e-05 | 199 | 86 | 5 | cefc3b50f65e95da850e4720c7b44bf584073491 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.19e-05 | 199 | 86 | 5 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Tracheal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.19e-05 | 199 | 86 | 5 | aaa460c389cd6d38a13ba1a446f91a94f9573ad8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal-BMP_responsible_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.29e-05 | 200 | 86 | 5 | 8433f4d3e26f6706bc7f06597d10b89221ce6437 | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.29e-05 | 200 | 86 | 5 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.29e-05 | 200 | 86 | 5 | 7c495030e6566b81d97b5516d1972e335ce5ed8c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.29e-05 | 200 | 86 | 5 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | mild-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.29e-05 | 200 | 86 | 5 | 334bab6bf93d455f3526e817ea5785d8b6ee531c | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.29e-05 | 200 | 86 | 5 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.29e-05 | 200 | 86 | 5 | 16a3685c41194a0a4a772e4eee372160263480e0 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.95e-05 | 104 | 86 | 4 | 11d91471b6c4fa6b00a91d9fd4db72ee60d1f801 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.95e-05 | 104 | 86 | 4 | 424a58b04c8b5108b70f15d8353c8e4b9db1e730 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.95e-05 | 104 | 86 | 4 | 9b05ae514437eb0c8b1b23607ae8cbc371ffa85b | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.60e-05 | 112 | 86 | 4 | 153614f307525af56501ac8f9c357c5f7de7882c | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.60e-05 | 112 | 86 | 4 | ba0bd3a77c4865a71fb92d195cd7459c562b63db | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.60e-05 | 112 | 86 | 4 | f9a796b4b5e227096ab360ca9ec08b1c564ac1eb | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.83e-05 | 113 | 86 | 4 | 0651fb7a7e1ea84b8365059e5ed85bf6c082da1a | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8-MURAL_Mural.Acta2Rgs5.Kcnj8-Abcc9_(Mural.Acta2Rgs5.Kcnj8-Abcc9)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.83e-05 | 113 | 86 | 4 | 0e153efddd061d7510dfc3859cc8b1a7984fa70e | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.50e-05 | 123 | 86 | 4 | 28be15b759c152662b29c323b1cc3f02f7830dbe | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_P2ry12|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.21e-04 | 131 | 86 | 4 | 80630812f8894b9358d36dc2dd03fea7ee870502 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.28e-04 | 133 | 86 | 4 | 63d2f096ae47d9b587acc6c5fbd346e5e58842b8 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 138 | 86 | 4 | c1a46fbf1beffa12c3d1b78361e0613e2e9e2d13 | |
| ToppCell | Endothelial-Endothelial-H_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 1.48e-04 | 138 | 86 | 4 | a1f41a5a9da40adcc343722baef78c603599c3f0 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-04 | 139 | 86 | 4 | 2fb51abb3ce88c21726c026d6365b2582e2e79f6 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.52e-04 | 139 | 86 | 4 | 7e2c10830c3d16109cab3ed0d64b3532481e497d | |
| Drug | GK-101 | 5.52e-11 | 36 | 84 | 7 | CID000161853 | |
| Drug | Madecassol | 3.44e-10 | 46 | 84 | 7 | CID000108062 | |
| Drug | d-indobufen | 6.33e-10 | 50 | 84 | 7 | CID000044562 | |
| Drug | ridogrel | 8.43e-10 | 52 | 84 | 7 | CID005362391 | |
| Drug | Selara | COL4A3 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 NR3C2 NOS3 | 8.82e-10 | 125 | 84 | 9 | CID000150310 |
| Drug | NSC49633 | 9.69e-10 | 53 | 84 | 7 | CID000023340 | |
| Drug | AC1LAKND | 3.01e-09 | 62 | 84 | 7 | CID000470146 | |
| Drug | ticlopidine | 4.37e-09 | 103 | 84 | 8 | CID000005472 | |
| Drug | malotilate | 7.93e-09 | 71 | 84 | 7 | CID000004006 | |
| Drug | BAPN | 7.93e-09 | 71 | 84 | 7 | CID000001647 | |
| Drug | PPACK | 9.13e-09 | 113 | 84 | 8 | CID003036757 | |
| Drug | AC1NMZ1B | 1.17e-08 | 75 | 84 | 7 | CID005034185 | |
| Drug | AC1Q6PCP | COL4A3 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 CACNA1G NR3C2 NOS3 | 1.31e-08 | 230 | 84 | 10 | CID000005267 |
| Drug | strontium ranelate | 1.41e-08 | 77 | 84 | 7 | CID006918182 | |
| Drug | halofuginone lactate | 2.82e-08 | 85 | 84 | 7 | CID000062891 | |
| Drug | DMSe | 3.10e-08 | 132 | 84 | 8 | CID000020796 | |
| Drug | 4-hydroxyproline | 4.55e-08 | 91 | 84 | 7 | CID000000825 | |
| Drug | PCR 4099 | 4.65e-08 | 139 | 84 | 8 | CID000002806 | |
| Drug | candesartan cilexetil | 6.46e-08 | 145 | 84 | 8 | CID000002540 | |
| Drug | hydroxylysine | 1.59e-07 | 109 | 84 | 7 | CID000001029 | |
| Drug | colchine | COL4A3 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 ACHE PKD1 ECEL1 NOS3 | 1.64e-07 | 383 | 84 | 11 | CID000002833 |
| Drug | AC1L1C2F | 1.69e-07 | 110 | 84 | 7 | CID000001711 | |
| Drug | AC1L9732 | 2.16e-07 | 114 | 84 | 7 | CID000439300 | |
| Drug | Tranilast sodium | 2.29e-07 | 115 | 84 | 7 | CID000005527 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 4.95e-07 | 189 | 84 | 8 | CID000001413 | |
| Drug | pirfenidone | 7.92e-07 | 138 | 84 | 7 | CID000040632 | |
| Drug | DL-penicillamine | 8.31e-07 | 139 | 84 | 7 | CID000004727 | |
| Drug | aspirin | COL4A3 COL4A5 COL4A6 COL24A1 COL6A2 AMH TRIT1 COL13A1 COL16A1 PLCB2 NOS3 GP5 | 1.04e-06 | 563 | 84 | 12 | CID000002244 |
| Drug | L-lysyl-L-lysyl-L-lysine | 2.32e-06 | 162 | 84 | 7 | CID000072363 | |
| Drug | AC1L18QD | COL4A3 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 PLCB2 NOS3 | 3.17e-06 | 325 | 84 | 9 | CID000000213 |
| Drug | khellin | 3.32e-06 | 171 | 84 | 7 | CID000003828 | |
| Drug | prostacyclin sodium salt | 4.01e-06 | 250 | 84 | 8 | CID000000159 | |
| Drug | AC1L1DD6 | 4.49e-06 | 179 | 84 | 7 | CID000002299 | |
| Drug | foscarnet | 6.64e-06 | 190 | 84 | 7 | CID000003414 | |
| Drug | losartan | COL4A3 COL4A5 COL4A6 COL24A1 COL6A2 COL13A1 COL16A1 NR3C2 NOS3 | 1.07e-05 | 378 | 84 | 9 | CID000003961 |
| Drug | calfactant | 3.22e-05 | 49 | 84 | 4 | ctd:C117342 | |
| Drug | CP-331 | 4.03e-05 | 3 | 84 | 2 | CID000130967 | |
| Drug | hyaluronan | 5.38e-05 | 263 | 84 | 7 | CID000024759 | |
| Drug | fluorosilicic acid | 8.03e-05 | 4 | 84 | 2 | CID011137276 | |
| Drug | Brn 2557402 | 8.03e-05 | 4 | 84 | 2 | CID000042742 | |
| Drug | silibinin | 8.90e-05 | 285 | 84 | 7 | CID000005213 | |
| Drug | Oxaprozin [21256-18-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 4530_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 4791_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 2269_UP | |
| Drug | Pirenperone [ 75444-65-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 5639_UP | |
| Drug | (cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; PC3; HT_HG-U133A | 9.54e-05 | 199 | 84 | 6 | 4543_DN | |
| Drug | cyclononane | 1.34e-04 | 5 | 84 | 2 | CID000136143 | |
| Drug | dimethylmalonimidate | 1.34e-04 | 5 | 84 | 2 | CID000189133 | |
| Drug | Cyclo-rgdphg | 1.34e-04 | 5 | 84 | 2 | CID006449872 | |
| Drug | chondroitin sulfate | 1.43e-04 | 413 | 84 | 8 | CID000024766 | |
| Drug | phenytoin | 1.61e-04 | 219 | 84 | 6 | CID000001775 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 1.62e-04 | 314 | 84 | 7 | CID000447989 | |
| Drug | cyclophorine | 1.77e-04 | 426 | 84 | 8 | CID000002909 | |
| Drug | 4-fluoranylproline | 2.00e-04 | 6 | 84 | 2 | CID000450594 | |
| Drug | PD 156707 | 2.00e-04 | 6 | 84 | 2 | ctd:C093321 | |
| Disease | Alport syndrome | 1.99e-08 | 3 | 81 | 3 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 1.99e-08 | 3 | 81 | 3 | cv:CN076135 | |
| Disease | collagen disease (implicated_via_orthology) | 2.56e-08 | 12 | 81 | 4 | DOID:854 (implicated_via_orthology) | |
| Disease | Hematuria, Benign Familial | 7.96e-08 | 4 | 81 | 3 | C0241908 | |
| Disease | Alport Syndrome | 7.96e-08 | 4 | 81 | 3 | C1567741 | |
| Disease | Alport Syndrome, X-Linked | 1.98e-07 | 5 | 81 | 3 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 1.98e-07 | 5 | 81 | 3 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 1.98e-07 | 5 | 81 | 3 | C1567744 | |
| Disease | albuminuria | 6.24e-06 | 94 | 81 | 5 | EFO_0004285 | |
| Disease | Leiomyomatosis, esophageal and vulval, with nephropathy | 7.44e-06 | 2 | 81 | 2 | C1839884 | |
| Disease | benign familial hematuria (is_implicated_in) | 7.44e-06 | 2 | 81 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | Alport syndrome, recessive type | 7.44e-06 | 2 | 81 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 7.44e-06 | 2 | 81 | 2 | C2931253 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 7.44e-06 | 2 | 81 | 2 | C4746745 | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 7.44e-06 | 2 | 81 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 7.44e-06 | 2 | 81 | 2 | C0403440 | |
| Disease | Benign familial hematuria | 7.44e-06 | 2 | 81 | 2 | cv:C0241908 | |
| Disease | Leiomyoma, Epithelioid | 7.44e-06 | 2 | 81 | 2 | C0086533 | |
| Disease | myopathy (implicated_via_orthology) | 9.35e-06 | 48 | 81 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Alport syndrome (is_implicated_in) | 2.23e-05 | 3 | 81 | 2 | DOID:10983 (is_implicated_in) | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 2.23e-05 | 3 | 81 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Renal glomerular disease | 3.39e-05 | 23 | 81 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 3.39e-05 | 23 | 81 | 3 | C4521256 | |
| Disease | lactosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement | 7.40e-05 | 5 | 81 | 2 | EFO_0800429 | |
| Disease | hypertensive nephropathy | 1.11e-04 | 6 | 81 | 2 | C0848548 | |
| Disease | urinary albumin to creatinine ratio | 1.37e-04 | 179 | 81 | 5 | EFO_0007778 | |
| Disease | end stage renal disease (is_implicated_in) | 1.97e-04 | 41 | 81 | 3 | DOID:783 (is_implicated_in) | |
| Disease | Alzheimer disease | 2.06e-04 | 8 | 81 | 2 | cv:C0002395 | |
| Disease | lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement | 2.65e-04 | 9 | 81 | 2 | EFO_0800517 | |
| Disease | body mass index, fasting blood glucose measurement | 3.77e-04 | 51 | 81 | 3 | EFO_0004340, EFO_0004465 | |
| Disease | CCL2 measurement | 4.09e-04 | 126 | 81 | 4 | EFO_0004749 | |
| Disease | Bladder Neoplasm | 6.09e-04 | 140 | 81 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 6.25e-04 | 141 | 81 | 4 | C0005684 | |
| Disease | urinary microalbumin measurement | 1.37e-03 | 20 | 81 | 2 | EFO_0010967 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 1.98e-03 | 24 | 81 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | fasting blood glucose measurement, HOMA-B, fasting blood insulin measurement | 2.14e-03 | 25 | 81 | 2 | EFO_0004465, EFO_0004466, EFO_0004469 | |
| Disease | HbA1c measurement | 2.56e-03 | 675 | 81 | 7 | EFO_0004541 | |
| Disease | Acute Confusional Senile Dementia | 2.59e-03 | 99 | 81 | 3 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 2.59e-03 | 99 | 81 | 3 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 2.59e-03 | 99 | 81 | 3 | C0750901 | |
| Disease | Presenile dementia | 2.59e-03 | 99 | 81 | 3 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 2.59e-03 | 99 | 81 | 3 | C0494463 | |
| Disease | Familial Alzheimer Disease (FAD) | 2.66e-03 | 100 | 81 | 3 | C0276496 | |
| Disease | Alzheimer's Disease | 2.74e-03 | 101 | 81 | 3 | C0002395 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VGCPPGGTGGNDTEL | 286 | P22303 | |
| APEDGQGCGDRGDPP | 6 | O14734 | |
| FLPPGEGPGLDGLCQ | 201 | Q8N944 | |
| PVIEEEPGGGGCPGS | 641 | Q8N350 | |
| EPGGGGCPGSGLCVL | 646 | Q8N350 | |
| CPPGRAQFGPGAGAG | 201 | O95936 | |
| APCGGGQLDPAAPGT | 686 | P55198 | |
| GPRGPPGLDGCNGTQ | 116 | Q14031 | |
| KCGDPGLPGPDGEPG | 681 | Q01955 | |
| GGPAAGPLAPRGDVC | 221 | O14514 | |
| EGDPGCVGSPGLPGP | 1011 | Q07092 | |
| EDLGGPCPEPGGDSG | 21 | Q7RTU4 | |
| PCPEPGGDSGVLGAN | 26 | Q7RTU4 | |
| IKGPRGDPGCPGAEG | 781 | P53420 | |
| GDPGCPGAEGPAGIP | 786 | P53420 | |
| FPGERGKPGAEGCPG | 916 | P53420 | |
| GPSGPGCKGEPGLDG | 1401 | P53420 | |
| GEVCGGPLALGGFDP | 676 | Q5T5Y3 | |
| RPNGCPGVGLGDPQA | 476 | Q9P2D1 | |
| GIPPGECFGLLGVNG | 1816 | Q8IZY2 | |
| PPFEGQAEGGGACPG | 96 | A0A1B0GUU1 | |
| PGPGPCEDPAGAGGA | 291 | Q86UR1 | |
| GRDGGGLAPPPGSCS | 431 | P10276 | |
| PVEPTAACGPGGGDG | 451 | O94810 | |
| LPQVCVGAEGPEGPG | 661 | Q12851 | |
| GGGPLGGPLKFSNPC | 211 | Q9H3H1 | |
| ELCGGPVPGEAPNGQ | 1296 | Q96RG2 | |
| GQEPAGCGDPQGGQP | 41 | A5PL33 | |
| AGGGPQEDCPGPGSG | 81 | Q86VZ4 | |
| GILGPPVPGFDGNCE | 471 | P08235 | |
| PGLGPKPGCTDLGTG | 366 | Q9UGP4 | |
| GQGPGSPEPINGELC | 216 | Q9HCH0 | |
| PSAPDGGCPQGGGNR | 321 | Q4ZG55 | |
| QGPGPRDGSPLLGGC | 521 | Q96JJ6 | |
| ITLDLPEGGGGGVPC | 431 | A6NKB5 | |
| RGPGACPQVEGLAGP | 676 | Q9ULL4 | |
| GGCPLQPKPEGPGED | 1346 | Q9ULL4 | |
| ACPEPGGGAEPDHGP | 36 | Q6PJ61 | |
| GGPGLSLCPPGGIQE | 71 | Q8N1N4 | |
| EAPADCGPEQGAGPG | 486 | Q50LG9 | |
| GAGAGLGTPPGGDVC | 86 | Q99687 | |
| CPGGPGGLGDPLRAL | 411 | P03971 | |
| TGACAGGPGLPAGEL | 221 | Q92985 | |
| EPPCGQFALPGGGAG | 226 | Q8TAK6 | |
| CGLLAGLPPPGAGQA | 81 | Q96ES6 | |
| GPVAAGGGACPEGCP | 86 | O95672 | |
| SVAQEPGPPCGLGLG | 6 | P29474 | |
| GQLGGGCPLRFEGPP | 811 | O94913 | |
| GPGLKADADGPPCGI | 251 | O14559 | |
| PDGVLPTIAPGACGG | 1966 | O60494 | |
| PLKDGGPGRGGCDNP | 181 | Q9ULW2 | |
| PTLRGDGGGGPPCGL | 286 | O43497 | |
| GDTGPQGDKGIAGCP | 1431 | A8TX70 | |
| SGGCPPAPGLESGVG | 71 | Q5VZB9 | |
| GHDGAPGPQGIPGCN | 111 | P29400 | |
| PGPQGIPGCNGTKGE | 116 | P29400 | |
| LGRIGPPGCKGDPGN | 336 | P12110 | |
| PPGCKGDPGNRGPDG | 341 | P12110 | |
| GGRPPGEPGGPFCLE | 276 | O95886 | |
| LAGGGIPEPHLGCPG | 6 | A8MYX2 | |
| DKGDAGEPGCPGSPG | 51 | B2RNN3 | |
| ELCQSPEGGFGGGPG | 131 | P49356 | |
| GLVGGEEPPRCAGPG | 441 | P40197 | |
| PGFRGGDCQEGPKDP | 111 | Q9BXX0 | |
| GDQGAPGLDAPCPLG | 691 | Q5TAT6 | |
| ETLGPGGGCSGEGPL | 11 | O15255 | |
| EGSGPGAIKCPGNDP | 61 | Q1W6H9 | |
| QGGQAGVPEGPGFCP | 41 | P25940 | |
| ALAGGPGRGCGPCEP | 21 | P98161 | |
| GPGSAGGHPQPCGVL | 16 | O60391 | |
| GPKGPCPGEEGEGVG | 356 | Q96JB3 | |
| PKEACGGAPLQGLPG | 256 | Q9Y6A5 | |
| GGAPLQGLPGEALGC | 261 | Q9Y6A5 | |
| QGLPGEALGCPAGVG | 266 | Q9Y6A5 | |
| EGPDACGGLPALGGP | 1636 | A2VEC9 | |
| GPAAGGLCLQPPDGG | 196 | P0DPB3 | |
| GAPAGPGAPGCGLAR | 6 | Q8TE76 | |
| CLQDGGSPPGPGDLA | 811 | Q96FS4 | |
| CRGPTPGQAPAGGAG | 481 | Q96NU1 | |
| PTGEPGGVGCQPDDG | 81 | A6NFY7 | |
| RGPAAGGLCLQPPDG | 271 | B3KU38 | |
| CSPLGGGEPSPGAGE | 331 | Q9ULL5 | |
| GNDGLPGAPGIPGEC | 71 | Q8IWL2 | |
| PGAPGIPGECGEKGE | 76 | Q8IWL2 | |
| GGGGGPQPAEPRCEI | 191 | P08913 | |
| RGAQGDQGPCGDPGL | 1371 | Q17RW2 | |
| DQGPCGDPGLKGQPG | 1376 | Q17RW2 | |
| AELPAPAGPGQGSGC | 41 | Q9NZR4 | |
| PAGPGQGSGCEGPAV | 46 | Q9NZR4 | |
| EGPAVAPCPGPGLDG | 56 | Q9NZR4 | |
| GSGPGLVGCLAGEPA | 936 | O94827 | |
| PRPQPGHCDGDGEGG | 46 | Q70EL4 | |
| SAECPEPGPGGLQGQ | 6 | Q6ZMD2 | |
| EDPGLCIDGAGLGGP | 501 | Q8IWN7 | |
| PPLGCGAVGGPVLEA | 171 | Q92610 | |
| VLGPGVEPGEVGGPC | 196 | A6XGL0 | |
| LAELGPPGVGGVGAC | 931 | Q00722 | |
| LCAEGNIQPGDPGPG | 111 | P52736 | |
| QAPGPGAAGGCGPEA | 26 | Q8N9V7 | |
| APAGACGGVLAPPAG | 701 | Q8IYT8 | |
| PTPLLPAACGVGGDG | 71 | A6NJT0 |